NCT04950244

Brief Summary

Conducting an analysis of the clinical performance of high-sensitivity cardiac troponin I, tested in the out-of-hospital setting, for ruling out cardiac origin in acute onset chest pain. Acute onset chest pain is a complex symptom to narrow down in the out-of-hospital setting. This is due to the difficulty of obtaining pertinent information over the phone, and the absence of validated dispatch scores or criteria. In France, the current standard of care relies on the rapid dispatch of Emergency Medical Response Teams along with a physician in patients presenting symptoms evocative of Coronary Artery Disease or Myocardial Infarction. Typical anginal pain includes retrosternal pressure pain radiating to the jaw, neck, or left arm. Diagnostic work-up includes anamnesis, physical examination, routine blood work, and ECG. In the absence of signification ST-segment modifications, the gold standard relies on trending serum Troponin T and I in the hospital setting . This study aims to analyze the clinical performance of high-sensitivity cardiac Troponin I assays (hs-cTnI) in the out-of-hospital setting using a point-of-care device ; Atellica VTLi (Siemens Healthineers)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 6, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

August 20, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2023

Completed
Last Updated

May 1, 2024

Status Verified

January 1, 2023

Enrollment Period

2.2 years

First QC Date

June 22, 2021

Last Update Submit

April 29, 2024

Conditions

Keywords

High-sensitivity cardiac Troponin ITroponin I HS

Outcome Measures

Primary Outcomes (1)

  • Clinical performance of hs-cTnI for rule-out of cardiac origin of chest pain in the out of hospital setting

    Determining the more appropriate cut off in terms of specificity and sensitivity to rule out chest pain in relation to coronary artery disease, based on the ROC curve.

    3 hours

Interventions

Capillary and veinous whole blood sampling for hs-cTnI was collected. The sample was tested at the bedside with a point-of-care device (Atellica VTLi, Siemens Healthineers). The result of both hs-c TnI values obtained was blinded to the treating physician

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

overall population of callers to the emergency dispatch center

You may qualify if:

  • Over 18 years of age
  • Presenting with evocative acute onset chest pain

You may not qualify if:

  • ECG modifications with ST segment elevations
  • Patients for whom anginal origin was excluded in the out-of-hospital setting
  • Medical evaluation in a delay inferior to 20 minutes
  • Patients without medical insurance
  • Pregnant or lactating women
  • Patients under reinforced guardianship, minors, patients in hospice care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Poitiers

Poitiers, 86000, France

Location

MeSH Terms

Conditions

Chest Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2021

First Posted

July 6, 2021

Study Start

August 20, 2021

Primary Completion

October 16, 2023

Study Completion

November 16, 2023

Last Updated

May 1, 2024

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations